Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Biologics and IASO Biotherapeutics to Present Updated Data from its Anti-BCMA CAR-T Therapy in Relapsed/Refractory Multiple Myeloma at European Hematology Association (EHA) Congress 2021-06-08 08:00
Live from ASCO 2021 | Ascentage Pharma Delivers Oral Presentation Featuring Updated Data Demonstrating Promising Efficacy and Safety of Bcl-2 Inhibitor Lisaftoclax (APG-2575) in Patients with Relapsed or Refractory CLL/SLL 2021-06-08 07:30
Live from ASCO 2021 | Ascentage Pharma Presents Updated Results of MDM2-p53 Inhibitor Alrizomadlin (APG-115) Demonstrating an ORR of 24.1% Including Complete Response in Combination with Pembrolizumab in Patients with Advanced Melanoma Resistant or Refractory to Prior Immuno-Oncologic Drugs 2021-06-08 07:21
Second Global Health Forum of Boao Forum for Asia: A Call for Innovation and Collaboration to Promote the Progress of the Global Health System 2021-06-07 21:35
ORTHO OPTIX™ Reader Completes Transfusion Medicine Portfolio, Now Available in the United States and Puerto Rico 2021-06-07 21:00
Elekta's new strategy to focus on growth and access to radiation therapy 2021-06-07 20:44
RedHill Biopharma Completes Enrollment of Oral Opaganib Phase 2/3 COVID-19 Study 2021-06-07 19:00
Device Companies will Drive Surgery Automation to Increase Elective Procedures in Western Europe 2021-06-07 18:02
L'OCCITANE Race for Vision 2021: United Against Blindness 2021-06-07 17:21
Clarivate Forecasts Nearly 70% of North American, European and Asia Pacific Adult Populations Will Be Vaccinated for COVID-19 by September 2021 2021-06-07 16:15
Elekta and Philips deepen strategic partnership in precise and individualized oncology care 2021-06-07 16:02
Alodokter Raises Fresh Capital from MDI Ventures and Samsung Ventures to Grow Ecosystem 2021-06-07 13:26
Cigna Study Shows Uncertainty about the Future Continues to be the Leading Cause of Stress 2021-06-07 12:00
China makes great efforts to contain COVID-19, saves more lives: SCO Secretary-General 2021-06-07 11:35
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Plus Paclitaxel/Cisplatin for the First-line Treatment of ESCC at ASCO 2021 2021-06-07 10:11
Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021 2021-06-07 10:10
BIAL Award in Biomedicine worth 300,000 Euros, nominations until 30 June 2021-06-07 10:00
Hyperice Named Official Recovery Technology Partner by League of Legends Pro League 2021-06-07 10:00
OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting 2021-06-07 10:00
Poster Highlighting Clinical Data of KN046 Plus Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Pancreatic Cancer Is Presented at ASCO 2021 2021-06-07 09:53
1 324 325 326 327 328 738